EC Number   |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
|---|
   1.1.1.50 | -999 |
- |
- |
389558, 655214, 655348, 656787, 669389, 673349, 675595, 687642 |
| 1.1.1.50 | -999 |
- |
age-dependent activities in vivo |
656642 |
| 1.1.1.50 | -999 |
- |
developemnt of noninvasive method for visualization and quantification of the reaction, development of selective fluorogenic substrate compounds, overview |
655790 |
| 1.1.1.50 | -999 |
- |
development of noninvasive method for visualization and quantification of the reaction, development of selective fluorogenic substrate compounds, overview |
655790 |
| 1.1.1.50 | -999 |
- |
isozyme AKR1C9 |
656651 |
| 1.1.1.50 | -999 |
- |
isozymes AKR1C1-AKR1C4 |
656651 |
| 1.1.1.50 | 0.00000023 |
- |
3alpha-hydroxysteroid dehydrogenase activity in the liver |
656648 |
| 1.1.1.50 | 0.00000027 |
- |
3alpha-hydroxysteroid dehydrogenase activity in the proximal intestine |
656648 |
| 1.1.1.50 | 0.00000032 |
- |
3alpha-hydroxysteroid dehydrogenase activity in the distal intestine |
656648 |
| 1.1.1.50 | 0.00002 |
- |
purified recombinant isozymes AKR1C1 and AKR1C3, substrate 3alpha-hydroxytibolone |
656838 |
